180 results
Page 6 of 9
6-K
EX-99.1
1dpms9n0ke045
29 Jan 20
Current report (foreign)
6:05am
6-K
EX-99.1
bbdwr6pbglhd
15 Jan 20
Current report (foreign)
6:06am
6-K
EX-99.1
zzkpabnr1 2bm3jf
13 Jan 20
Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosis
6:06am
6-K
EX-99.1
mac5jfxh
20 Dec 19
Gilead submits new drug application to U.S. Food and Drug Administration under priority review for filgotinib for rheumatoid arthritis treatment
6:01am
6-K
EX-99.1
k8fyg5qkdv6mzk
9 Dec 19
Galapagos completes recruitment of NOVESA trial in systemic sclerosis
10:11am
6-K
EX-99.1
kxh2zj
12 Nov 19
Current report (foreign)
6:15am
6-K
EX-99.1
i1sdpmh
29 Oct 19
MOR106 clinical development in atopic dermatitis stopped for futility
6:00am
6-K
EX-99.1
lfol7s 1s8s145tdz
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.2
jbzhqtyz9fjfrm824pd
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.1
5d06g 5wznukw
11 Oct 19
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks In Finch 1 and Finch 3 Studies In Rheumatoid Arthritis
6:00am
6-K
EX-99.1
6ayiq6e3qrgi9h
25 Sep 19
Current report (foreign)
10:50am
6-K
EX-99.1
vbmobammkru86mmo57ad
5 Sep 19
European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis
5:24pm
6-K
EX-99.2
rhil3n87
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.1
acrq3nc7
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.3
rcii 2u01ha
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99
5usb3
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99
5jjrx8 lbsmx
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99.1
4acbettrpo
15 Jul 19
Gilead and Galapagos Enter into Transformative Research and Development Collaboration
11:59am
6-K
EX-99.1
3hqefc6sgyjx8c6z
2 Jul 19
Gilead Announces Intent to Submit New Drug Application for Filgotinib to U.s. Food and Drug Administration This Year
6:08am
6-K
EX-99.1
apagyglwr
11 Jun 19
Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
6:05am